Canada markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.8900+0.5900 (+17.88%)
At close: 04:00PM EDT
3.8900 0.00 (0.00%)
After hours: 07:13PM EDT
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-760,500
-760,500
-211,600
219,500
305,800
Depreciation & amortization
125,100
125,100
143,300
123,800
114,500
Deferred income taxes
-8,900
-8,900
-28,600
46,000
-3,300
Stock based compensation
23,100
23,100
45,100
42,400
51,800
Change in working capital
-70,300
-70,300
-2,100
-145,000
9,500
Accounts receivable
-21,600
-21,600
118,100
-16,200
27,500
Inventory
600
600
-57,100
-66,600
-66,900
Accounts Payable
10,600
10,600
-14,000
-1,600
28,300
Other working capital
-257,900
-257,900
-149,900
96,100
395,000
Other non-cash items
34,500
34,500
13,100
9,000
29,600
Net cash provided by operating activites
-206,300
-206,300
-34,100
320,200
536,900
Cash flows from investing activities
Investments in property, plant and equipment
-51,600
-51,600
-115,800
-224,100
-141,900
Acquisitions, net
-
-
-
-
0
Other investing activites
-6,300
-6,300
-265,500
-
-10,000
Net cash used for investing activites
212,300
212,300
-381,300
-224,100
-151,900
Cash flows from financing activities
Debt repayment
-563,400
-563,400
-33,800
-35,900
-387,100
Common stock issued
8,400
8,400
0
0
-
Common stock repurchased
0
0
-82,100
-106,000
0
Other financing activites
-2,500
-2,500
-5,900
-15,000
-25,000
Net cash used privided by (used for) financing activities
-535,700
-535,700
481,200
-141,000
69,700
Net change in cash
-530,900
-530,900
66,300
-45,200
453,500
Cash at beginning of period
642,600
642,600
576,300
621,500
168,000
Cash at end of period
111,700
111,700
642,600
576,300
621,500
Free Cash Flow
Operating Cash Flow
-206,300
-206,300
-34,100
320,200
536,900
Capital Expenditure
-51,600
-51,600
-115,800
-224,100
-141,900
Free Cash Flow
-257,900
-257,900
-149,900
96,100
395,000